Today: 17 May 2026
Intel stock slips as analyst tone shifts ahead of earnings
16 January 2026
1 min read

Intel stock slips as analyst tone shifts ahead of earnings

New York, Jan 16, 2026, 09:41 EST — Regular session

Shares of Intel Corp (INTC) slipped 0.8% to $48.32 in early Friday trading, hitting the brakes after a strong rally earlier this year.

The pullback arrives as investors debate if the upbeat sentiment around Intel’s turnaround can last until next week’s earnings, with a focus on its contract chipmaking efforts. Intel has surged 31% in 2026, but some money managers note a sharp shift in mood. “It’s back from the dead,” said Kim Forrest, chief investment officer at Bokeh Capital Partners. The Business Times

Citi raised Intel to Neutral from Sell and bumped its price target to $50 from $29, citing “tightness” in advanced packaging supply at Taiwan Semiconductor Manufacturing Co. Advanced packaging, the process that connects multiple chiplets into a finished processor, is under pressure. TipRanks

RBC Capital’s Srini Pajjuri kicked off coverage with a Sector Perform rating and set a $50 price target. He praised management for a “commendable job” but warned of short-term challenges. Higher memory prices and supply constraints could weigh on revenue and margins, he noted. Manufacturing yield visibility also remains uncertain. TipRanks

Intel’s move comes as chip stocks rally this week following TSMC’s positive outlook on growth and its announcement to boost U.S. manufacturing capacity, sparking a lift in sector sentiment.

For Intel, the focus isn’t just on a single quarter — it’s about delivering proof. Bulls are looking for stronger signals that it can secure and sustain outsourced manufacturing deals against bigger contract chipmakers, all while maintaining healthy profits.

Intel plans to release its fourth-quarter and full-year 2025 earnings after markets close on Jan. 22, followed by a conference call at 2 p.m. PT.

Still, the situation is double-edged. A slip in margins or a weak update from external foundry clients might shake a stock that’s already moved swiftly.

U.S. markets will be closed Monday in observance of Martin Luther King Jr. Day, paving the way for a shortened week packed with earnings reports, especially in tech and other sectors.

Stock Market Today

  • Berkshire Hathaway CEO Greg Abel Revamps Portfolio with Major Stock Changes
    May 16, 2026, 7:29 PM EDT. Berkshire Hathaway, under new CEO Greg Abel, has significantly overhauled its equity portfolio in Q1, highlighted by a 224% increase in Alphabet shares, now Berkshire's seventh largest holding valued at $16.6 billion. Abel added Delta Air Lines and Macy's, while cutting multiple stocks, including a near-total sale of Constellation Brands and complete exit from Amazon shares. The largest reduction by value was in Chevron, cut by 35%, worth over $8 billion. The reshuffle marks a shift away from holdings linked to former portfolio manager Todd Combs, indicating a strategic realignment under Abel's leadership. Alphabet has gained 38% since the quarter ended.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Microsoft stock slips as Italy probes Activision game sales and Swiss watchdog eyes Microsoft 365 fees
Previous Story

Microsoft stock slips as Italy probes Activision game sales and Swiss watchdog eyes Microsoft 365 fees

Intel stock treads water as Citi upgrade meets TSMC-fueled chip rally
Next Story

Intel stock treads water as Citi upgrade meets TSMC-fueled chip rally

Go toTop